Vestmark Advisory Solutions Inc. Sells 32,245 Shares of CorVel Corp. $CRVL

Vestmark Advisory Solutions Inc. reduced its position in CorVel Corp. (NASDAQ:CRVL) by 53.7% during the second quarter, HoldingsChannel reports. The firm owned 27,781 shares of the business services provider’s stock after selling 32,245 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in CorVel were worth $2,855,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Xponance Inc. boosted its position in shares of CorVel by 4.9% during the 1st quarter. Xponance Inc. now owns 2,008 shares of the business services provider’s stock valued at $225,000 after purchasing an additional 94 shares in the last quarter. Ballentine Partners LLC grew its position in shares of CorVel by 4.2% during the 1st quarter. Ballentine Partners LLC now owns 2,531 shares of the business services provider’s stock worth $283,000 after buying an additional 102 shares during the period. Atria Investments Inc increased its stake in shares of CorVel by 1.3% in the 2nd quarter. Atria Investments Inc now owns 14,646 shares of the business services provider’s stock valued at $1,505,000 after acquiring an additional 186 shares in the last quarter. Vanguard Personalized Indexing Management LLC increased its stake in shares of CorVel by 4.1% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 5,534 shares of the business services provider’s stock valued at $569,000 after acquiring an additional 217 shares in the last quarter. Finally, Meeder Asset Management Inc. acquired a new position in shares of CorVel during the 1st quarter valued at $25,000. 51.36% of the stock is owned by institutional investors.

CorVel Price Performance

CRVL opened at $75.97 on Friday. CorVel Corp. has a fifty-two week low of $70.47 and a fifty-two week high of $128.61. The firm has a market capitalization of $3.90 billion, a PE ratio of 39.16 and a beta of 0.98. The company’s 50-day moving average is $78.01 and its 200 day moving average is $93.12.

CorVel (NASDAQ:CRVL) last issued its quarterly earnings data on Tuesday, November 4th. The business services provider reported $0.54 EPS for the quarter. The firm had revenue of $239.64 million during the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.

Analysts Set New Price Targets

CRVL has been the topic of several research reports. Wall Street Zen lowered shares of CorVel from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings restated a “hold (c)” rating on shares of CorVel in a report on Tuesday, October 14th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.

Insider Buying and Selling at CorVel

In related news, CFO Brandon O’brien sold 1,764 shares of the stock in a transaction on Monday, September 8th. The stock was sold at an average price of $91.54, for a total value of $161,476.56. Following the completion of the sale, the chief financial officer directly owned 8,948 shares of the company’s stock, valued at approximately $819,099.92. This represents a 16.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Maxim Shishin sold 12,000 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $89.16, for a total transaction of $1,069,920.00. Following the completion of the sale, the insider owned 7,050 shares of the company’s stock, valued at approximately $628,578. This represents a 62.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 44.56% of the company’s stock.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.